endoscopic sclerotherapy

endoscopic sclerotherapy

The treatment of esophageal varices–EVs by endoscopic injection of a sclerosant–sodium tetradecyl sulfate into the veins; ES has been used to manage bleeding EVs; medical therapy may be more effective and have fewer complications, vis-à-vis control of active bleeding, prevent recurrences, and survival; ES may be equal or superior to other non-medical management–eg, insertion of a portacaval shunt, or selective splenorenal shunt for survival and preservation of liver function Complications Rebleeding–± 50%, esophageal ulceration, strictures, perforations, rebleeding, fever–40%, pulmonary and renal effects, and death in 1-2%. See Endoscopic ligation, Esophageal varices, Nadolol with isosorbide mononitrate.
References in periodicals archive ?
Since its introduction, endoscopic sclerotherapy of bleeding oesophageal varices, where variceal banding is not feasible, has remained the mainstay treatment for haemodynamically stable patients and where clotting abnormalities have been corrected.
We analysed the outcome of endoscopic sclerotherapy performed with injection tract embolisation and its relationship to the underlying aetiology.
Oesophageal variceal bleeding secondary to portal hypertension; Endoscopic sclerotherapy as first step treatment.
Endoscopic sclerotherapy for control of bleeding varices in children.
Prophylactic endoscopic sclerotherapy of large osephago- gastric varices in infants with biliary atresia.
Comparison and Characterization of Ulcerations Induced by Endoscopic Ligation of Esophageal Varices Versus Endoscopic Sclerotherapy.
Secondary Prophylaxis of Oesophageal Variceal Treatment: Endoscopic Sclerotherapy, Band Ligation and Combined Therapy--Long--Term, Results.
These approaches include specific medical therapy for Crohn disease, vasopressin infusion, infliximab, endoscopic sclerotherapy, or angiographic intervention and surgery.
Endoscopic sclerotherapy has been investigated in these patients, but it is not recommended for primary prevention because it is associated with a high rate of adverse events.
The trials, examined the effectiveness of treatment with endoscopic sclerotherapy or band ligation alone or in combination with somatostatin, octreotide, or vapreotide.

Full browser ?